Li Chen Hsiao
Voorzitter bij Sinopac Assets Co. Ltd.
Oorsprong van het eerstegraads netwerk van Li Chen Hsiao
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
YFY Biotech Management Co
 YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund
2
| Subsidiary | Investment Managers | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Li Chen Hsiao via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| National Taiwan University | College/University | Undergraduate Degree Graduate Degree | |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Pharmaceuticals: Major | Director/Board Member | |
| Shionogi Bioresearch Corp. | Founder | ||
| Fuji Immunopharmaceuticals Corp. | Founder | ||
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| MYCENAX BIOTECH INC. | Biotechnology | Director/Board Member | |
| PHARMIGENE, INC. | Pharmaceuticals: Generic | Director/Board Member | |
| TAIWAN LIPOSOME COMPANY, LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
NeuroSky, Inc.
 NeuroSky, Inc. SemiconductorsElectronic Technology NeuroSky, Inc. develops biosensor technology services. Its biosensors, biometric algorithms, reference designs, and big data analytics enable leading-edge innovation in mhealth products and services for measuring body and mind performance. The company was founded by Hyung Koo Lee and Jong Jin Lim in 2004 and is headquartered in San Jose, CA. | Semiconductors | Director/Board Member | |
| Taiwan Genome Sciences, Inc. | Director/Board Member | ||
| TAIMED BIOLOGICS INC. | Biotechnology | Director/Board Member | |
| National Yang Ming University | College/University | Undergraduate Degree | |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
Taiwan Global BioFund
 Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| National Health Insurance /Taiwan/ | Chief Executive Officer | ||
| TWI BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
MiCareo Taiwan Co., Ltd.
 MiCareo Taiwan Co., Ltd. BiotechnologyHealth Technology MiCareo Taiwan Co., Ltd. provides tools for the analysis of rare cells. | Biotechnology | Chairman | |
MiCareo, Inc.
 MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | Biotechnology | Director/Board Member | |
| SUNNY PHARMTECH INC. | Medical/Nursing Services | Director/Board Member | |
| SOMNICS, INC. | Electronic Equipment/Instruments | Director/Board Member | |
| MEDEON BIODESIGN, INC. | Electronic Equipment/Instruments | Director/Board Member | |
| IXENSOR CO., LTD. | Medical Specialties | Director/Board Member | |
| SYNEURX INTERNATIONAL (TAIWAN) CORP. | Biotechnology | Director/Board Member | |
| AP BIOSCIENCES INC | Biotechnology | Director/Board Member | |
| CHO PHARMA, INC. | Biotechnology | Chief Executive Officer | |
| TANVEX BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Medeon Biosurgical, Inc. | Director/Board Member | ||
| Sunny Pharma Holding Ltd. | Director/Board Member | ||
| Medeon International, Inc. | Director/Board Member | ||
Delos Advisors Ltd.
 Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
LipoSeuticals, Inc.
 LipoSeuticals, Inc. Pharmaceuticals: MajorHealth Technology LipoSeuticals, Inc. operates as a specialty pharmaceuticals firm that focuses on the development of next-generation proprietary formulations of sterile injectable drugs, principally aimed at the domains of anesthesiology, oncology and infectious disease. It develops formulation of non-water-soluble drugs. The firm’s products include parenteral dosage forms and oral dosage forms. The company was founded by Wu Nian in 2012 and is headquartered in Monmouth Junction, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| FORMOSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EUSOL BIOTECH CO.,LTD. | Biotechnology | Chief Executive Officer | |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Biotechnology | Director/Board Member | |
Curamir Therapeutics, Inc.
 Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA. | Biotechnology | Founder | |
| ACEPODIA, INC. | Biotechnology | Director/Board Member | |
| Taiwan Pharmaceutical Manufactureres Association | President | ||
| EXCELSIOR BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Taiwan | 27 |
| Verenigde Staten | 12 |
| Hongkong | 4 |
| Kaaimaneilanden | 3 |
| Australië | 2 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 5 |
| Finance | 4 |
| Electronic Technology | 4 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 32 |
| Chief Executive Officer | 5 |
| Founder | 4 |
| Chairman | 4 |
| President | 4 |
Sterkste connecties
| Insiders | |
|---|---|
| Hong Jen Chang | 34 |
| Lan Bo Chen | 13 |
- Beurs
- Insiders
- Li Chen Hsiao
- Bedrijfsconnecties